Maolac Ltd.
Biomed — Stage: Initial Revenues. Est: 2021. Tags: Alternative Proteins, Artificial Intelligence, Biotechnology, Deep Tech, Food Additives, FoodTech, Industrial, Life Sciences, MedTech. Maolac's product, in the form of gummy candies, is based on the development of an Israeli startup that produces protein powder with unique properties from cow's milk. The company develops innovative bioactive ingredients, inspired by human breast milk, based on cow colostrum and plant sources. Maolac produces three products: the first for intestinal health and the proliferation of the microbiome, the bacteria that live in the body; the second for skeletal muscle recovery after sports training or for the elderly for better mobility; and the third is Super Colostrum, designed to strengthen the immune system.. Web: https://www.maolac.com